Faron Pharmaceuticals Oy Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-27.26	-25.92	-30.94	-28.73	-21.19	Upgrade
Depreciation & Amortization	0.33	0.31	0.35	0.3	0.31	Upgrade
Stock-Based Compensation	1.82	0.69	2.45	1.3	1.49	Upgrade
Other Operating Activities	6.99	7.21	1.1	-0.63	-1.06	Upgrade
Change in Accounts Payable	0.67	-4.09	2.99	0.72	0.72	Upgrade
Change in Other Net Operating Assets	-0.47	-0.5	0.25	4.05	-2.49	Upgrade
Operating Cash Flow	-17.92	-22.3	-23.81	-22.99	-22.22	Upgrade
Capital Expenditures	-	-0	-	-	-0.01	Upgrade
Sale (Purchase) of Intangibles	-0.22	-0.23	-0.12	-0.39	-0.46	Upgrade
Other Investing Activities	0.2	0.36	-	-	0	Upgrade
Investing Cash Flow	-0.02	0.14	-0.12	-0.39	-0.47	Upgrade
Long-Term Debt Issued	25	3.2	0.06	10.39	0.66	Upgrade
Long-Term Debt Repaid	-9.03	-3.53	-1	-0.22	-0.31	Upgrade
Net Debt Issued (Repaid)	15.97	-0.33	-0.94	10.17	0.35	Upgrade
Issuance of Common Stock	12.12	31.85	26.03	13.45	25.56	Upgrade
Other Financing Activities	-7.45	-6.73	-1.11	-0.14	-0.32	Upgrade
Financing Cash Flow	20.64	24.79	23.98	23.48	25.59	Upgrade
Foreign Exchange Rate Adjustments	0.11	0.01	-0.17	0.04	-0.15	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0	Upgrade
Net Cash Flow	2.81	2.63	-0.11	0.14	2.75	Upgrade
Free Cash Flow	-17.92	-22.31	-23.81	-22.99	-22.23	Upgrade
Free Cash Flow Per Share	-0.16	-0.25	-0.37	-0.42	-0.44	Upgrade
Cash Interest Paid	0.39	1.03	1.33	0.82	0.04	Upgrade
Cash Income Tax Paid	0	0.04	-	-	0.02	Upgrade
Levered Free Cash Flow	-11.34	-17.96	-12.86	-12.45	-13.55	Upgrade
Unlevered Free Cash Flow	-10.55	-15.5	-11.53	-11.59	-13.42	Upgrade
Change in Working Capital	0.2	-4.6	3.24	4.77	-1.76	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.